NSEGeneral Updates5d ago · 4 Nov 2026, 06:38 pm
General Updates
Gufic Biosciences Limited · GUFICBIO
✦ AI SummaryRegulatory
Gufic Biosciences Limited has received an order from the Income Tax Appellate Tribunal (ITAT) regarding the assessment under Section 143(3) read with Section 144B of the Income Tax Act, 1961, for the Assessment Year 2023-24. The order allows the Income Tax Department's appeal and the Company's cross-objection for statistical purposes, setting aside the findings of the Commissioner of Income Tax (Appeals) and restoring the matters to the file of the Assessing Officer for fresh consideration.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gufic Biosciences Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
GUFIC_04112026183618_finalintimation.pdf
View document text
338/LG/SE/NOV/2026/GBSL
November 04, 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex,
Dalal Street, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code : 509079 Scrip Symbol : GUFICBIO
Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
Dear Sir/Madam,
In continuation of our earlier intimations dated March 19, 2025, April 14, 2025 and April 03, 2026 and
pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), this is to inform that the Company
has, on November 04, 2026, received an order dated October 15, 2026, passed by the Hon’ble Income
Tax Appellate Tribunal (ITAT), Mumbai, in respect of the assessment under Section 143(3) read with
Section 144B of the Income Tax Act, 1961 (“the Act”) for the Assessment Year 2023-24.
Pursuant to the Assessment Order dated March 18, 2025, a tax demand of Rs. 11,88,88,580/- was
raised against the Company, which was subsequently reduced to Rs. 11,76,198/- by the Commissioner
of Income Tax (Appeals) [“CIT(A)”].
The Income Tax Department filed an appeal before the ITAT against the relief granted by the CIT(A),
while the Company filed a cross-objection against the disallowance sustained by the CIT(A). By the
aforesaid order, the ITAT has allowed both the Department’s appeal and the Company’s cross-
objection for statistical purposes, set aside the findings of the CIT(A), and restored the matters to the
file of the Assessing Officer for fresh consideration in accordance with law. The tax liability, if any, will
be determined upon completion of the fresh assessment proceedings.
The details required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 issued thereunder are as
below:
Particulars Details
1. Name of the Authority
Income Tax Appellate Tribunal, Mumbai
2. Nature and details of the action(s) Order dated October 15, 2026, bearing ITA No.
taken, initiated or order(s) passed 7885/MUM/2025 and CO No. 30/MUM/2026 for
Assessment Year 2023-24, whereby the appeal filed
by the Income Tax Department and the cross-
objection filed by the Company have been allowed
for statistical purposes.
3. Date of receipt of direction or Order dated October 15, 2026, received by the
order, including any ad-interim or Company on November 04, 2026.
interim orders, or any other
communication from the authority
4. Details of the violation(s) or The matter relates to certain disallowances made
contravention(s) committed or during the assessment proceedings for Assessment
alleged to be committed. Year 2023-24.
5. Impact on financial, operation or No demand arises from the said order and there is no
other activities of the listed entity, impact on the operations of the Company. The tax
quantifiable in monetary terms to liability, if any, will be determined upon completion
the extent possible. of the fresh assessment proceedings. The Company
will take appropriate steps to protect its interests.
Kindly take the same on your record.
Thanking You,
Yours truly,
For Gufic Biosciences Limited
Ami Shah
Company Secretary & Compliance Officer
Membership No. A39579